One evening last spring, Robert Pyatt was scrolling through social media when an advertisement popped up for an at-home genetic test for COVID-19. According to the ad, the test could say if you’re prone to the virus, and also give your risk of severe symptoms should you end up sick.
“What is this?” Pyatt thought.